IP Library Granted Patent US 9,410,173
Granted Patent B2
US 9,410,173 · App. 14/058,038 · Granted Aug 9, 2016

Template switch-based methods for producing a product nucleic acid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,410,173
App. No.
14/058,038
Granted
Aug 9, 2016
Kind
B2
Abstract

Provided are methods of producing a product nucleic acid. The methods include combining a template deoxyribonucleic acid (DNA), a polymerase, a template switch oligonucleotide, and dNTPs into a reaction mixture. The components are combined into the reaction mixture under conditions sufficient to produce a product nucleic acid that includes the template DNA and the template switch oligonucleotide each hybridized to adjacent regions of a single product nucleic acid that includes a region polymerized from the dNTPs by the polymerase. Aspects of the invention further include compositions and kits.

Claims (22)

1. A method comprising:

combining:

a template deoxyribonucleic acid (DNA);

a retroviral reverse transcriptase;

a template switch oligonucleotide;

a first DNA primer comprising a 3′ domain that hybridizes to the template DNA; and

dNTPs;

into a reaction mixture under conditions sufficient to produce a product nucleic acid, wherein the product nucleic acid comprises the template DNA and the template switch oligonucleotide each hybridized to adjacent regions of a single hybrid nucleic acid comprising a region polymerized from the dNTPs by the retroviral reverse transcriptase, wherein the region polymerized from the dNTPs comprises a domain that is complementary to and hybridized to the 5′ end of the template DNA.

2. The method according to claim 1 , wherein the template switch oligonucleotide comprises a 3′ hybridization domain and a 5′ adapter sequence.

3. The method according to claim 2 , wherein the 3′ hybridization domain comprises a homo-trinucleotide.

4. The method according to claim 2 , wherein the 3′ hybridization domain comprises a hetero-trinucleotide.

5. The method according to claim 4 , wherein the hetero-trinucleotide comprises a nucleotide comprising cytosine and a nucleotide comprising guanine.

6. The method according to claim 1 , wherein the template switch oligonucleotide comprises a modification that prevents the retroviral reverse transcriptase from switching from the template switch oligonucleotide to a different template nucleic acid after synthesizing the complement of the template switch oligonucleotide.

7. The method according to claim 1 , wherein the method further comprises contacting a 3′ region of the single hybrid nucleic acid with a second strand primer configured to bind thereto under hybridization conditions.

8. The method according to claim 1 , wherein the method further comprises subjecting the single hybrid nucleic acid to nucleic acid amplification conditions.

9. The method according to claim 1 , wherein the template DNA is single stranded.

10. The method according to claim 1 , wherein the template DNA is double-stranded.

11. The method according to claim 10 , wherein the double-stranded template DNA comprises a 3′ overhang.

12. The method according to claim 11 , wherein the method further comprises producing the template DNA from a precursor double-stranded DNA.

13. The method according to claim 12 , wherein the method comprises contacting the precursor double-stranded DNA with a terminal transferase under conditions sufficient to produce the template DNA.

14. The method according to claim 12 , wherein the method comprises contacting the precursor double-stranded DNA with a restriction enzyme to produce the template DNA.

15. The method according to claim 2 , wherein the first DNA primer comprises a 5′ adapter sequence.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2016
From: BOLDUC, NATHALIE
To: TAKARA BIO USA, INC.
Reel/Frame 040346/0019 →
CHANGE OF NAME Recorded Aug 4, 2016
From: CLONTECH LABORATORIES, INC.
To: TAKARA BIO USA, INC.
Reel/Frame 039584/0025 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2014
From: BETTS, CRAIG; FARMER, ANDREW ALAN
To: CLONTECH LABORATORIES, INC.
Reel/Frame 031909/0937 →